Rats by Intratracheal Intermittent Administration: Yuri SANO, et al. Department of Preventative Medicine and Public Health, School of Medicine, Keio University-Although bismuth is widely used as a lead substitute in the industrial field, the toxicity of bismuth by inhalation is little known. We performed a 13-wk intratracheal intermittent bismuth dose toxicity study. Bismuth was administered at dose levels of 0, 0.8, 4, 20 mg/kg to male Crj:CD(SD)IGS rats (SPF) by intratracheal intermittent administration once a week for thirteen weeks to investigate its potential toxic effects; especially for specific adverse effects and changes related to pre-neoplastic lesions. Our results showed foreign body inflammation in the lungs, which was caused by intratracheal administration of bismuth, and physical changes related to pulmonary lesions; however, there were no serious changes in other organs. We concluded that dose-dependent, but not specific adverse effects, were attributable to bismuth inhalation in the rat. (J Occup Health 2005; 47: 242-248) 
conditions. Recently bismuth compounds are recommended for the treatment of drug-resistant Helicobactor pylori infections, combined with antibiotics 2) . High-level exposure to bismuth compounds in clinical use, such as bismuth sodium triglycocollamate or triglycollate, caused acute renal failure associated with degeneration and necrosis of the epithelium of the renal proximal tubules 3) . Fatty changes and necrosis of the liver, reversible dysfunction of the nervous system, and skin eruptions and pigmentation of the gums and intestine were also reported as systemic effects of bismuth compounds in human 4) . Although, bismuth is considered to be barely absorbed by inhalation, cutaneous exposure, or ingestion, there are no quantitative data. Once bismuth is absorbed, it is transported into the blood, bound to metallothionein and distributes throughout the tissues, resulting in the manifestations of bismuth toxicity described above 5) . Previously, we reported the toxic effect of bismuth through repeated oral administration for twenty-eight days at dose levels between 0 and 1,000 mg/kg daily into SD rats 6) . In these studies, we found no changes attributable to bismuth up to the dose level 1,000 mg/kg in both sexes. Consequently we determined the no-observed-adverse-effect levels (NOAEL) of bismuth to be 1,000 mg/kg. For reference, NOAEL of lead has been determined to be 20 mg/ kg for male rats and 8 mg/ kg for female rats. The exposure to bismuth in the industrial field mainly occurs by inhalation; thus, we performed evaluation of the toxicity of bismuth by 13-wk intratracheal intermittent administration.
Materials and Methods

Chemicals
Bismuth (purity, 99.9%, CAS No.: 7440-69-9, particle diameter: 1-2 µm) was provided by Kojundo Chemical Laboratory Co., Ltd. After receipt, the test substance was stored at room temperature.
Animals
Forty-eight male Crj:CD(SD)IGS rats (SPF) were obtained from Charles River Japan, Inc. After a 7-day quarantine and acclimatization period, the animals were assigned to experimental groups to provide homogeneous distributions of the body weights among each group on the day before administration. At the start of administration, the 6-wk-old animals weighed 197-229 g.
The animals were fed a pellet diet (MF, Oriental Yeast Co., Ltd.) and given tap water irradiated by UV rays after passing through a 5-µm filter ad libitum. The rats were housed under the following conditions: temperature of 22 ± 2°C, relative humidity of 55 ± 15%, ventilation frequency of about 12 changes per hour, and lighting for 12 h per day (7:00 to 19:00).
Administration Single dose intratracheal toxicity study
Prior to the 13-week intratracheal toxicity study, in order to obtain information for selection of dose levels and interval of administration in the study, bismuth was administered once intratracheally to 6-wk-old male SD rats (body weight: 205-248 g) at doses of 0, 20, 100, and 500 mg/kg. Five animals of each group were subjected to necropsy at 2, 4, 8, and 15 d after administration. We conducted histopathological examinations on the lungs from all animals including the control group. Furthermore, the concentration of bismuth in the lungs at necropsy was measured as follows. Ten percent homogenate of the lung samples, which were frozen immediately after the necropsy, were prepared using 0.9% saline. An aliquot of the homogenate was accurately weighed and put into a PFA vial (Taf-tainer vial, GL Science, Tokyo). Digestion was performed in a microwave oven (MLS-1200 MEGA, Milestone, Italy) after the addition of 0.4 ml concentrated nitric acid and 0.2 ml hydrogen peroxide (Tama pure AA 100, Tama Chemicals, Kawasaki). The digestion program was as follows: 250 W for 5 min, 0 W for 1 min, 250 W for 5 min, 400 W for 5min, and 600 W for 5 min. The digested samples were diluted with Milli-Q purified water (>18 MΩ) up to 1.0 ml, followed by appropriate dilution with 0.5% nitric acid. The concentrations of bismuth were measured by a microwave-induced plasma mass spectrometer (MIP-MS, P-7000, Hitachi) at m/z 209, where Eu (m/z 153) was used as an internal standard.
13-wk intratracheal intermittent dose toxicity study
In the 13-wk intermittent toxicity study the highest dose level was chosen as 20 mg/kg, since the result of the single dose toxicity study showed that 20 mg/kg did not cause death. The low and middle dose levels were set as 0.8 and 4 mg/kg, respectively. Considering the accumulation of bismuth in the lungs by repeated administration and its effects on the physical condition of the animals, it was decided that the dose interval should be once a week to keep a steady-state concentration of bismuth in the lungs, because in the single dose study, the bismuth concentration in the lungs decreased rapidly in each treatment group up to 8 days after administration, but thereafter it did not fluctuate largely.
Bismuth was weighed in to amounts of 0.032, 0.16 and 0.8 g and mixed with 20 ml of 0.5% carboxymethylcellulose sodium solution (Iwai Chemicals Co., LTD. and Wako Pure Chemical Industries Co., Ltd.) for the dosing suspensions. The dose volume was set at 0.5 ml/kg and the individual dose volume was calculated on the basis of the body weight measured just before administration on each administration day. The dosing suspensions were intratracheally administered to the twelve animals of each dosing group. The control group was treated with the vehicle (0.5% carboxymethylcellulose sodium solution).
Clinical signs, body weights and food consumption
Clinical signs of the animals were observed twice a day (before and after administration) throughout the dosing period, and once a day in the morning during the other period. The body weights of all animals and the gross weights of the feeders were measured once a week.
Hematology and blood chemistry
On days of the scheduled necropsy, the animals were anesthetized by intraperitoneal injection of sodium thiopental (Ravonal, Tanabe Seiyaku Co., Ltd.). Thereafter, blood samples were collected via the posterior vena cava. For hematology, we measured the erythrocyte count (RBC), hemoglobin concentration (Hb), hematocrit value (Ht), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), reticulocyte count, platelet count (PLT), prothrombin Time (PT), activated partial thromboplastin time (APTT), leukocyte count (WBC), and differential leukocyte count. For blood chemistry, we measured the aspartatate aminotransferase (ASAT), alanine aminotransferase (ALAT), γ-glutamyltrasferase (γGT), alkaline phosphatase (ALP), total bilirubin, blood urea nitrogen (BUN), creatinine, glucose, total cholesterol, triglycerides, total protein, albumin, A/G ratio, calcium, inorganic phosphorus, sodium (Na), potassium (K), and chlorine (Cl).
Urinalysis
Fresh urine samples from all the surviving animals were collected on the day before scheduled necropsy. pH, protein, glucose, ketone bodies, bilirubin, occult blood, and urobilinogen were measured.
Pathological and histopathological examination
After the blood sampling, all animals were sacrificed by exsanguinations via the abdominal aorta, and then subjected to necropsy. The following organs of all animals were weighed: brain, liver, kidney, spleen, and testis. Relative organ weights were calculated from body weights on each necropsy day. We conducted histopathological examinations on the lung, liver, kidney, spleen, brain, and testis from the control and 20 mg/kg groups and gross lesions from all animals including the control group. The organs except for testes were fixed by 10% neutral phosphate-buffered formalin solution. The testes were fixed in Bouin's solution. The hematoxylin and eosin stained specimens were prepared according to the standard procedure and then microscopically examined. Furthermore, PAS stained specimens of the kidneys from three animals were prepared to confirm the change of the glomerulus. Berlin blue stained specimens of the spleen from three animals were prepared to confirm that the brown pigments found in the spleen were hemosiderin.
Statistical analysis
We used a multiple comparison test to analyze statistical significances in the numerical data (body weight, food consumption, hematology, blood chemistry, and organ weights). If there was statistical significances in the data between groups, Dunnett's test or Dunnett type rank-sum test was conducted. Statistical significance in graded categorical data (urinalysis, necropsy findings and histopathological findings) was analyzed by a × b chi-square test. If statistically significant data were found, we conducted Cochran-Armitage trend test. Significance levels of 5% and 1% were chosen for all statistical analyses.
Results
The concentration of bismuth in the lung
The time course of the concentration of bismuth in the lungs after administration is shown in Fig. 1 . The kinetics of bismuth can be described with a one-compartment pharmacokinetic model, since the logarithms of the lung concentrations of bismuth versus time plotted for each dosing group yield straight lines. From the slope of these lines, we calculated the half-life of bismuth elimination from the lungs as 4.47, 3.25, 2.10 d for the doses of 20, 100, 500 mg/kg, respectively.
Clinical signs, body weight and food consumption
No abnormal clinical signs or food consumption attributable to bismuth administration were observed in any treated group during the testing period. Two animals of the control group, two animals of the 20 mg/kg group, one animal of the 4 mg/kg group, and one animal of the 0.8 mg/kg group died. A possible cause of death in these animals was excessive anesthesia at administration or suffocation just after the administration associated with the intratracheal dose. In other changes, loss of hair was observed in one and two animals in the 4 and 20 mg/kg groups, respectively. Suppression of body weight gain was observed at Day 29 and thereafter in the 20 mg/kg group, but it was not statistically significant.
Hematology and blood chemistry
Hematology and blood chemistry changes are shown in Table 1 . A slight increase in erythrocyte count and MCHC were observed in the 20 mg/kg group, and slight increases in hemoglobin concentration and hematocrit value were observed in the 4 mg/kg and higher groups. Higher rates of segmented neutrophil were observed in the 4 mg/kg and higher groups, and lower rates of lymphocytes were observed in the 0.8 mg/kg and higher groups. An increase in urea nitrogen was observed in the 20 mg/kg group. We observed a decrease in ASAT in the 4 mg/kg group, however, this was considered to be an incidental change, because it was not observed in the high dose group.
Urinalysis
There were no significant differences between the control group and any treated group in the urinalysis. (data not shown)
Pathological and histopathological examinations
The absolute and relative lung weights increased in the 0.8 mg/kg and higher groups (Table 1) . Increases in the relative brain and kidney weights were observed in the 20 mg/kg group, however, it was considered to be an incidental change related to decreased body weight, since suppression of body weight gain was also observed in the 20 mg/kg group and there was no difference in the absolute organ weight.
The necropsy and histopathological findings are shown in Table 2 . Pathological changes attributed to bismuth administration were observed in the lungs and bronchial lymph nodes. In the lungs, a brown patch was observed in 3, 4, and 8 animals of the 0.8, 4 and 20 mg/kg groups, respectively. Black patches originating from the color of bismuth and collapses were observed in all animals of the 4 and 20 mg/kg groups. Furthermore, enlargement of bronchial lymph nodes was observed in 6, 5, and 10 animals of the 0.8, 4, and 20 mg/kg groups, respectively. A brown patch in the lungs also observed in one animal 0.9 ± 0.0 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 Ca mg/dl 9.5 ± 0.2 9.5 ± 0.2 9.6 ± 0.3 9.4 ± 0.2 P mg/dl 6.5 ± 0.4 6.7 ± 0.6 6.7 ± 0.5 6.6 ± 0.5 Na mmol/l 147.6 ± 0. in the control group, and slight focal inflammatory cell infiltration with small hemmorrhage was observed in this lesion microscopically. A white patch in the liver was observed in 1, 2, and 3 animals of the 0.8, 4, and 20 mg/kg groups, respectively. Although, it was not statistically significant, there was a dose dependent trend of increase in number of animals which had a white patch. This necropsy finding was possibly related to bismuth. As an incidental change, abnormal lobulation of the liver and cyst in the kidney were observed in one animal of the 0.8 mg/kg group.
In the necropsy of 4 of 6 animals that died during the administration period, the following changes were observed in one animal of the 4 mg/kg group: dilatation and hemorrhage of the urinary bladder, possibly related to death, and other changes such as renal pelvic dilatation, ascites, small sized thymus and spleen, and black patch, dark red change and collapse of the lungs. The cause of death in this animal may have been anuria; it was considered to be an incidental mortality, since it occurred in only one animal.
Histopathological changes attributed to bismuth were observed in the lungs, bronchial lymph nodes and kidneys.
Focal inflammatory cell infiltration in the lungs was observed in all animals in the 0.8 mg/kg and higher groups. The incidence of lesions increased dosedependently. In the lesions of inflammatory cell infiltration, hypertrophy of alveolar epithelial cells was observed in the 0.8 mg/kg and higher groups, and hyperplasia of bronchial epithelial cells was observed in the 4 mg/kg and higher groups. A typical hematoxylin and eosin stained histopathological image of the lung is shown in Fig. 2 . Inflammatory cell infiltration in the 0.8 mg/kg and higher groups, hypertrophy of alveolar epithelium in the 4 mg/kg and higher groups, and hyperplasia of bronchial epithelial cell in the 20 mg/kg group showed statistically significant differences, as compared with the control group. Aggregation of foamy cells was observed in all groups including the control group and increased significantly in the 20 mg/kg group. Microscopic accumulation of bismuth was observed in all animals of the 4 and 20 mg/kg groups, and showed statistically significant differences as compared with the control group.
In enlarged bronchial lymph nodes observed macroscopically, hyperplasia of the para-cortical area was observed, and increased pigment-laden phagocytic cells including the test substance was observed in 3 and 10 animals of the 4 and 20 mg/kg groups, respectively. In other changes, hyaline droplet of the proximal tubular epithelium in the kidney was observed in all groups including the control group, and its incidence decreased significantly in the 20 mg/kg group. The kidneys of representative animals of the control and 20 mg/kg groups were stained by PAS method, since a change in the glomerulus was suspected. In the result, there were no changes in the glomerulus and the hyaline droplets were PAS negative. Additional examination of the liver was conducted, since an effect of bismuth on the liver was suspected. Focal fatty degeneration of hepatic cells was observed in 1 and 2 animals of the 4 and 20 mg/kg groups, respectively. Brown pigment of the spleen was confirmed to be a hemosiderin pigment by Berlin blue staining.
Discussion
We observed slight increases in erythrocyte count, MCHC, hemoglobin concentration and hematocrit value. These changes were caused by relative polycythemia due to plasma exudation into the bronchus and alveoli associated with pulmonary inflammation, or absolute polycythemia. We observed an increase in urea nitrogen in the 20 mg/kg group. This may have been related to increases in nitrogenous components caused by destruction of exuded plasma protein and blood cells in the bronchus and alveolus, and it is possible that relative polycythemia was observed due to the blood concentration in the 20 mg/kg group.
Although a high rate of segmented neutrophil and low rate of lymphocyte were observed, when the absolute number of the segmented neutrophils and the lymphocytes were calculated, the segmented neutrophil value was still high, while the lymphocyte value was not low. Therefore, we considered these changes were related to the pulmonary inflammation. Increased lung weights, dose-dependent focal inflammatory cell infiltration in the lungs, and observation of hypertrophy of alveolar epithelial cells may have been the result of foreign body inflammation caused by the intratracheal administration.
Hyperplasia of the para-cortical area in the bronchial lymph nodes is often observed with aggregation of macrophages when foreign body inflammation of the lungs occurs 7) , so the lesions observed in the present study may have been the result of a physiological reaction to the bismuth dosed intratracheally.
Generally, the acute response of pulmonary damage is characterized by inflammation to remove the inciting particle and cellular debris. If this process is successful, complete resolution can happen; however if injury or subsequent inflammation is severe due to persistence of inciting particles, irreversible pulmonary damage may follow 8) . In the single dose toxicity study, pulmonary inflammatory changes of the 20 mg/kg group showed a recovery tendency, but the changes in the 100 and 500 mg/kg groups showed no recovery tendency. Therefore, we considered that the pulmonary toxicity of bismuth by single administration 20 mg/kg can be completely resolved, but at doses of more than 100 mg/kg, irreversible pulmonary damage may take place. The repair of these pulmonary effects in repeated administration of bismuth is unknown because we did not set up a recovery period in this 13-wk intermittent dose toxicity study. However, the short half-life of bismuth elimination from the lungs, which was estimated to take from 2.10 to 4.47 d in the single dose toxicity study, suggests that bismuth has high clearance in the lung. Additionally, bismuth does not cause specific pulmonary effects such as fibrosis produced by silica 8) , therefore, we predict that once the particles are eliminated from the lungs, the pulmonary damage will regress.
We observed other histopathological changes in hyperplasia of bronchiolar epithelium in the 20 mg/kg group. The line between hyperplasia and alveolar/ bronchiolar adenoma is equivocal 9) . Therefore, we can not exclude the possibility that this hyperplasia was neoplastic lesions. The observation of continuous spectrum is not set analyzed. However, the lung tumor response in rats following the inhalation of particles, including no mutagenic activity particles, at high concentrations may be indicative of carcinogenic potential 8) . Even if the bronchiolar changes seen in the present study were neoplastic lesions, they may not have been specific to bismuth but not specific to particles.
The hyaline droplets which normal male rats spontaneously develop in the proximal tubular epithelium cell cytoplasm consist of α 2µ globulin. This poorly hydrolysable low molecular weight protein is PAS negative 10) . The result that the hyaline droplets observed in our study were PAS negative, suggest that these hyaline droplets did consist of α 2µ globulin. Hyaline droplets reflect normal glomerular filtration with proximal convoluted tubule uptake and accumulation of low molecular weight protein in the epithelial cell cytoplasm 10) . In our result, since glomerul change was not observed by the PAS staining method, the glomerular filtration also may not have changed. We considered it possible that normal glomerular filtration and decreased proximal tubule uptake might cause a decrease in incidence of hyaline droplets. As described in the introduction, kidney damage, such as proximal tubules of epithelial cells containing intranuclear inclusion bodies resembling those seen in lead toxicity, by bismuth salts was reported in humans, but we did not observe intranuclear inclusion bodies. Also in the urinalysis, proteinuria was observed in most animals, but there was no significant difference between the control group and the exposed groups. Since there was no clear evidence for proximal tubule damage by bismuth in this study, the reason for the decrease in incidence of hyaline droplets is not known.
Focal fatty degeneration of hepatic cells was not considered to be related to bismuth, since it is a spontaneous change observed often in rats and occurred in only a small number of animals.
In summary, dose-dependent foreign body inflammation of the lungs due to intratracheal administration of bismuth and physical change related to the pulmonary lesions were induced by intratracheal administration of bismuth once a week for 13 wk.
We conclude that bismuth inhalation causes dosedependent but not specific adverse effects.
